Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Sales5886848841 0461 1591 272
Operating income (EBITDA)136161231285323360
Operating profit (EBIT)-120185240274308
Pre-Tax Profit (EBT)-105170229261292
Net income67,572,5139160184209
P/E ratio24,934,239,039,734,729,6
EPS ( € )0,820,791,511,691,932,26
Dividend per Share ( € )0,200,220,330,370,420,68
Yield0,98%0,81%0,56%0,56%0,62%1,01%
Reference price ( € )20.308326.883358.966.966.966.9
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Debt-87,486,477,726,4-
Finance-----92,9
Operating income (EBITDA)136161231285323360
Leverage
(Debt/EBITDA)
-0,54x0,37x0,27x0,08x-
Capital Expenditure29,347,153,071,676,278,2
Book Value Per Share (BVPS)-5,78 €6,96 €8,12 €9,87 €11,8 €
Cash Flow per Share-1,21 €1,52 €2,15 €2,46 €2,70 €
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 167 M€ -
Entreprise Value (EV) 6 245 M€ 6 193 M€
Valuation 2016e 2017e
P/E ratio (Price / EPS) 39,7x 34,7x
Capitalization / Revenue 5,90x 5,32x
EV / Revenue 5,97x 5,34x
EV / EBITDA 21,9x 19,2x
Yield (DPS / Price) 0,56% 0,62%
Price to book (Price / BVPS) 8,24x 6,78x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,9% 23,6%
operating Leverage (Delta EBIT / Delta Sales) 1,64x 1,31x
Net Margin (Net Profit / Revenue) 15,3% 15,9%
ROA (Net Profit / Asset) 12,6% 12,8%
ROE (Net Profit / Equities) 22,3% 21,1%
Rate of Dividend 22,0% 21,6%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,85% 6,57%
Cash Flow / Sales 19,0% 19,6%
Capital Intensity (Assets / Sales) 1,22x 1,24x
Financial Leverage (Net Debt / EBITDA) 0,27x 0,08x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend